PRELUDE CAPITAL MANAGEMENT, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2016$50,000
-21.9%
1,100
-31.2%
0.01%
-44.4%
Q2 2016$64,000
+14.3%
1,6000.0%0.01%
+12.5%
Q1 2016$56,0000.0%1,600
+23.1%
0.01%
-11.1%
Q4 2015$56,000
+33.3%
1,300
+18.2%
0.01%
+50.0%
Q4 2014$42,000
+7.7%
1,1000.0%0.01%
+20.0%
Q3 2014$39,0001,1000.01%
Other shareholders

There were no reported owners of BIOSPECIFICS TECHNOLOGIES CO in Q2 2016.

NameSharesValueWeighting ↓
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders